Open access
3,186
Views
5
CrossRef citations to date
0
Altmetric
Articles
Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials
Alice B. Gottlieba Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence[email protected]
View further author information
, View further author information
Jashin J. Wub Dermatology Research and Education Foundation, Irvine, CA, USAView further author information
, Christopher E. M. Griffithsc Dermatology Centre, Salford Royal NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, The University of Manchester, Manchester, UKView further author information
, Kwaku Marfod Novartis Pharma AG, Basel, SwitzerlandView further author information
, Elisa Muscianisie Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
, Xiangyi Menge Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
, Jennifer Fruehd Novartis Pharma AG, Basel, SwitzerlandView further author information
& Mark Lebwohla Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
show all
Pages 1482-1490
|
Received 27 Aug 2020, Accepted 23 Sep 2020, Published online: 21 Oct 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.